Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Gut|January 1, 1995
Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatmentW Uddin, J K Ramage, B Portmann, et al.
Reviews in Endocrine & Metabolic Disorders|November 6, 2020
Evaluating cost-effectiveness in the management of neuroendocrine neoplasmsB E White, R Mujica-Mota, T Snowsill, et al.
Gut|February 1, 1996
p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitisP M Rizzi, S D Ryder, B Portmann, et al.
Gut|May 1, 1987
Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological studyM Deakin, H P Glenny, J K Ramage, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1988
Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel diseaseR T Jenkins, J K Ramage, D B Jones, et al.
Lancet (London, England)|August 14, 1993
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varicesA E Gimson, J K Ramage, M Z Panos, et al.
ISRN Oncology|March 28, 2013
ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine TumoursRajaventhan Srirajaskanthan, A Ahmed, A Prachialias, et al.
British Journal of Cancer|January 17, 2013
Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumoursG Yadegarfar, L Friend, L Jones, et al.
Gastroenterology|November 1, 1994
Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantationP M Rizzi, P A Kane, S D Ryder, et al.
British Journal of Cancer|January 27, 2011
Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21E Friend, G Yadegarfar, C Byrne, et al.
Pageof 4